Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6257 of 6351
-
Knee replacement study pulled before it even started
Knowledge-focused CancelledEvaluation of clinical outcomes and patient recovery in patients receiving TKA with traditional instrumentation systems compared to full arc of motion gap balancing using the Newton TM Knee Protocol
Sponsor: Newton-Wellesley Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Early study checks how well new drug tablet works in healthy people
Knowledge-focused CompletedThis is a multiple part, multiple cohort study evaluating single and multiple ascending doses, relative bioavailability, food effect, and drug-drug interaction of NX-5948 in healthy volunteers.
Phase 1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New gel could mean fewer applications for knee pain relief
Knowledge-focused CompletedThe aim of the present study is to investigate the systemic bioavailability of AMZ001, applied once daily on each knee compared to Diclofenac diethylammonium gel 1.16%, applied 4 times daily on each knee, after repeated dosing in healthy subjects for 7 days The safety and local t…
Phase 1 • Sponsor: Amzell • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Generic diabetes pill matches brand in healthy volunteer test
Knowledge-focused CompletedProspective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study
Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New pouch aims to make mealtimes safer for Huntington's patients
Symptom relief CancelledPrimary Objectives * To assess the acceptability of using the DoddleBags feeding aid in people with HD, by using a food diary to track food intake and using semi-structured interviews to ask questions about how easy or difficult it was to use a DoddleBag for each meal compared t…
Sponsor: University of Hull • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Healthy volunteers test new Drug's body processing
Knowledge-focused CompletedA study to compare the pharmacokinetics, safety and immunogenicity of SIM0718 injection in healthy adult subjects in China
Phase 1 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Pfizer launches early safety trial for new eczema drug
Knowledge-focused CompletedThe purpose of this study is to learn about the safety of the study medicine called PF-08049820 in healthy adults. The study will also see: * how the body processes the study medicine and * if food affects the amount of study medicine in the blood. The study medicine is develop…
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Sep 09, 2026 17:00 UTC
-
Healthy volunteers test new drug SPY002-091 for first time
Knowledge-focused CompletedThis is a Phase 1, randomized, double-blind, placebo-controlled, single- dose, first in human safety, tolerability, and pharmacokinetic study of SPY002-091 in healthy participants.
Phase 1 • Sponsor: Spyre Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New biologic injection takes on steroids for rotator cuff pain — but study pulled
Symptom relief CancelledThe goal of the study is to see which is better at treating patients which rotator cuff tendinopathy (RCT): a single injection of Connective Tissue Matrix boost (CTM) or a steroid shot. Patients will be randomized (like flipping a coin) to the treatment. Patients and researchers…
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Standing or lying down? study tests best way to measure ankle strength
Knowledge-focused CompletedThe purpose of this study is to investigate whether there is a difference in ankle dorsiflexor, hallux dorsiflexion and plantar flexor muscle strength measured in the supine position compared with the standing position. Muscle strength assessments are commonly performed in differ…
Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Scientists decode how the brain picks what to look at
Knowledge-focused CompletedHow does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. One can only attend to a small location on the picture at a given moment, so to…
Sponsor: University of California, Santa Barbara • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
MRSA decolonization kit trial stalls after just one patient
Disease control Stopped earlyStaphylococcus aureus (S. aureus) is a leading cause of healthcare-associated infections worldwide. S. aureus colonizes several body sites, including the nose, throat, and perineum. Colonization by methicillin-resistant S. aureus (MRSA) increases the risk of infection by up to 27…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug S-740792 tested in healthy volunteers for first time
Knowledge-focused CompletedThis is a 3-part study of S-740792 in healthy adult participants. Part 1 (single-ascending-dose and food effect) will investigate the safety, tolerability, and pharmacokinetics (PK) of S-740792. Part 2 (multiple-ascending-dose and drug-drug interaction) will investigate the safet…
Phase 1 • Sponsor: Shionogi • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New drug M6229 put to the test in healthy people
Knowledge-focused CompletedThis is a Phase I, single-center, randomized, single-blind, placebo-controlled study in healthy subjects assessing the safety, tolerability and pharmacokinetic profile of three different dose levels of M6229 when administered continuously for 120 hours.
Phase 1 • Sponsor: Matisse Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
One hard bike ride could change your balance and brain – study reveals
Knowledge-focused CompletedThe project involves conducting a series of motor, physiological, biochemical, and psychological tests. The series of tests within the experiment will assess the effect of a single aerobic exercise (graded test) on changes in sensory organization and balance performance (based o…
Sponsor: University School of Physical Education, Krakow, Poland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Survey reveals what ICU nurses know about ventilator care
Knowledge-focused CompletedTo assess intensive care unit (ICU) nurses' knowledge regarding initiation of mechanical ventilation and associated nursing procedures in hospitals of a southern in Iraq.
Sponsor: Aqeel Azeez Arrar • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Plastic bag trick to warm preterm babies never tested
Disease control CancelledThe purpose of this study is to determine whether the combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care reduces the incidence of moderate (…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug RPT1G tested in humans for first time
Knowledge-focused CompletedThis is a first-in-human (FIH), randomized, double-blind, placebo-controlled, single and multiple dose study with staggered dose escalations in healthy participants.
Phase 1 • Sponsor: Remedy Plan, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:22 UTC
-
New antibody drug HB0056 begins first human safety trial
Knowledge-focused Recruiting nowThe aim of this study is to investigate the safety and tolerability of HB0056 in healthy subjects following single-dose.
Phase 1 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:18 UTC
-
Heart failure drug study pulled before it started
Symptom relief CancelledThe goal of this randomized double-blind crossover study is to assess whether a morning dose of the extended release torsemide has a better efficacy than the ordinary immediate release torsemide to induce renal sodium excretion after a salty lunch in patients with stable heart fa…
Phase 2 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC